CYduct Diagnostics Inc (CYDX)

[highflier]

UPDATED COMPREHENSIVE DD ON SNDY...

This sums up what SNDY is doing to grow their business.
Anyone wanting to invest in a company needs to see how the company is spending their money. If they waste money to me that is not a good investment. If a company is spending money to grow a business model and the market they are entering is a large enough market that a company can take market share and increase their revenue then it makes it a good investment as well. So with that said let's look at what SNDY has done with their money in the past year. Here is a company that has investors that are spending big money buying SNDY preferred shares. Remember this, investors that buy preferred shares are buying into the future of the company.

BIG money is purchasing SNDY preferred shares.
I have put together a list of the shares and the amount of money SNDY received by going thru their financial since 2nd Q 2011.

In the 2nd Q 2011 SNDY sold 4,000 preferred B stock options for $40,000 in cash. Bottom of Pg.19 of 4Q 2011 report.

In the 4th Q 2011 SNDY owed a contractor $400,000. This contractor took $400,000 worth of preferred B stock options and then gave SNDY $55,000 in cash for the purchase of additional shares. Pg.20 of 4Q 2011 report.

In the 1st Q 2012 a consultant received 26,000 shares of preferred B stock options for payment due of $260,000. Also they sold 10,900 share of preferred B stock options for $109,000 in cash. The entire board of SNDY also gave up their 150,000,000 shares of common stock to take preferred B stock options as well. Pg.15 of 1Q 2012 report.

In the 2nd Q 2012 the company sold 38,580 shares of preferred B stock options for 395,800 in cash. Also an officer and director took 27,015 shares of preferred B stock options for the conversion of $111,240 owed to him. Pg.15 of 2q 2012 report.

In the 3rd Q 2012 the company sold 26,150 shares of preferred B stock options for $261,500 in cash. Also the president recieved 450,000 shares of preferred B stock options for $450,000 owed to him for the signing of an employee contract and personal guarantees to the company. Pg.15 of 3q 2012 report.

There is obviously some major players with really deep pockets that have heavily invested into the future of SNDY. In cash advances to company alone they have received $861,300. Over 3/4 million dollars. Not to mention the contractors, consultants, and one officer receiving shares for money owed, in the amount of $771,240. Actually more cash money went into SNDY then people taking stock options as payments. That should say a lot. So we see that $1,632,540 in cash and stock option payments have been invested into the future of SNDY in a very short time. There is no one that is going to invest this kind of money into SNDY without knowing the payoff will be rewarding.

So was all this money put to good use? The thing is SNDY is putting the money they are getting from selling this preferred shares and common shares to great use. They didn't just take the money they got from selling these shares and blow it on themselves. SNDY has been very transparent on what they have used the money for.

SNDY payed off over $1.1 million dollars in debt last year last year. Also by being near debt free it makes it so much easier to run a company, more profitable and they do not waste money on interest. Same thing as when we run our household. We are limited on what we can do if we are in debt up to our eyes. SNDY could of just left the company in major debt which would of been a strangle hold on the company and caused them to just burn thru all the money they received from selling their shares. If they had done that I would of sold and moved on to investing my money else where. But they did not do that.

SNDY let us know last year they spent $35,000 to hire Expert Resource to help them in securing the CE mark. They hired one of the best in the business, a company that has NEVER failed to get the CE mark for their clients. So once again this company put the money to good use. And so far the first Audit passed and Expert Resource will help them for the second Audit. And don't forget they also hired TUV SUD America to Complete ISO 13485 Certification and Audit. ER will get the CE mark for SNDY, remember they have a 100% track record for getting this done.
Once again the company is putting the money they have raised to great use.

Also SNDY last year continued to spend money on bringing out new innovative products last year like the Steri-Tap, and bariatric line of instruments. Great way to put our money to good use by bring out new innovative products in a multi billion dollar market.

And last but not least SNDY made a great effort to grow their balance sheet to $3.4 million. That makes the company very attractive for any partnership/merger. It's all on record if we read the financial statement. It was also posted as well.
www.bizjournals.com/boston/blog/mass-high-tech/2012/11/solos-endoscopy-ends-q3-with-34m-in-the-bank.html

Then after all this we see that SNDY is making a name for itself in the laparoscopic and endoscopy market being mentioned with some BIG NAME companies on the major stock exchanges.

SOLOS ENDOSCOPY MENTIONED IN $3.6 MILLION LAPAROSCOPIC ARTICLE...

US Laparoscopic Device Market to Grow Moderately to Nearly $3.6 Billion by 2017Growth Driven by Increasing Demand for Minimally Invasive Procedures, According to Millennium Research Group

January 14, 2013—Toronto—According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the United States market for laparoscopic devices will grow moderately, reaching a value of $3.59 billion by 2017. Growth will come largely from expanding procedure volumes, as the demand for minimally invasive techniques continues to grow. Direct energy, hand assist and single-port devices will grow most quickly.

Laparoscopic procedures will grow significantly faster than open surgeries through 2017 as surgeons continue to take advantage of the patient benefits of laparoscopic techniques, such as faster recovery, less post-operative pain, and better cosmetic results. Bowel resections will be the fastest growing laparoscopic procedure, followed by sleeve gastrectomies and hernia repairs. Sleeve gastrectomies will grow at the expense of gastric banding, which has suffered from safety and efficacy concerns.

Single-port procedures will grow strongly, driven by uptake in high-volume procedures such as cholecystectomies and appendectomies. These are procedures where surgeons are either extremely experienced with laparoscopic techniques, or where the anatomy lends itself to straightforward access from the umbilicus.

Robotic techniques will also show strong adoption in urological and gynecological procedures, particularly in prostatectomies, partial nephrectomies and hysterectomies.

“Outside of these growth segments, there is a strong emphasis on cost cutting,” said MRG Analyst Chantal Dougan. “Reusable and reposable products have taken ground from disposable products, particularly in the access device and hand instrument segments. While disposable products generate higher per-procedure revenues, over the next few years the conversion to reusable devices will aid revenues, as facilities invest in entire sets of reusables.”

CareFusion, Solos Endoscopy and Integra LifeSciences all launched modular reusable hand instruments in 2012 to combine convenience with cost-savings.

Learn more about this Medtech 360 Report

US Markets for Laparoscopic Devices 2013

Includes unit, installed base, average selling price and revenue information, along with market drivers and limiters and competitive landscape access devices, direct energy devices, internal closure devices, hand instruments, hand-assist devices, suction/irrigation devices, insufflation devices, laparoscopes, gastric bands and laparoscopic single-port devices sold in the United States.

http://mrg.net/News-and-Events/Press-Releases/US-Markets-for-Laparoscopic-Devices-011413.aspx

Carefusion is trading on the NYSE for $32/share, Integra Lifescience is trading on the NASDAQ for $43/share. Here we see Solos is getting mentioned with some big name companies. These people writing these article know the products SNDY has. And out of all the companies they could of mentioned they DID MENTION SNDY!! SNDY spending the money last year to bring out new products is going to pay off big time. They know their market and are taking every step to position themselves to be a player in this market.

I had been told they were making major strides with their new instruments to be a major player in the Laparoscopic Industry. Now I'm starting to see just how big this market really is. And remember they are trying to get a longer shelf life on their instruments. You would have to be blind not to see what this company is doing. If they only get 1/4 percent of the 3.6 billion dollar Laparoscopic Industry that will bring them in $9,000,000 in revenue. Not to mention the $2.6 billion Endoscopy Industry. If they only get 1/4 percent of the Endoscopy market that will bring them in another $6,500,000. That is a total of $15,500,000. And even if they only get 1/8 percent of the market share of both of those markets that will give them $7,500,000 in revenue. Don't think for one minute that SNDY is not serious about getting the CE mark for all their equipment. Remember to get the CE mark they have to have a partnership in place to distribute their products. Once that happens big sale numbers will follow.

I'm proudly sitting on my 60 million shares and was happy to follow all the money being invested into this great company. I will patiently wait for this story to unfold like all the great long term investors on this board. Things don't always happen as fast as we would like. But with what SNDY has done over the past year that was a pretty big undertaking. And with Expert Rescoures behind them to get the CE mark I will trust their past results. Really happy to be part of this great family of investors that have seen the long term plan of this company as well. Want to welcome all the new investors coming in this past week as well.

You can believe who you want on where this is about to go. I would suggest you do your own DD and not listen to what is posted over and over on a message board. With the major amount of DD I've done with this company I know I will follow what I have found out about SNDY. There is a reason all these people have been buying SNDY preferred B stock options. Remember over $1.6 million worth of stock options have been purchased in the past year. Why in the world would these investors invest $1.6 million dollars in this company if they did not believe it was going somewhere? Smart investors don't just throw away that kind of money. We are not talking about $16,000 we are talking about $1.6 million dollars. Not to mention the common shares that have been accumulated. And don't forget the insiders gave up all their common stock and took preferred stock options last year. I don't know about you guys but I'm going to continue to follow the big money going into this company.

Take care my friends,
Mike